Global Varicella Vaccine Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Description

According to our (Global Info Research) latest study, the global Varicella Vaccine market size was valued at USD 4294.8 million in 2023 and is forecast to a readjusted size of USD 7108.9 million by 2030 with a CAGR of 7.5% during review period.

Varicella vaccine, also known as chickenpox vaccine, is a vaccine that protects against chickenpox. One dose of vaccine prevents 95% of moderate disease and 100% of severe disease. Two doses of vaccine is more effective than one. If given to those who are not immune within five days of exposure to chickenpox it prevents most cases of disease. Vaccinating a large portion of the population also protects those who are not vaccinated. It is given by injection just under the skin
Global Varicella Vaccine key players include Merck, Shanghai Institute, Changsheng, Keygen, GSK, etc.

Asia is the largest market, with a share over 35%, followed by US and Europe, both have a share over 55%.

In terms of product, Freeze-Dried Powder is the largest segment, with a share over 50%. And in terms of application, the largest application is Kids Injection, followed by Adults Injection, etc.

The Global Info Research report includes an overview of the development of the Varicella Vaccine industry chain, the market status of Kids Injection (Injection, Freeze-Dried Powder), Adults Injection (Injection, Freeze-Dried Powder), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Varicella Vaccine.

Regionally, the report analyzes the Varicella Vaccine markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Varicella Vaccine market, with robust domestic demand, supportive policies, and a strong manufacturing base.

Key Features:
The report presents comprehensive understanding of the Varicella Vaccine market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Varicella Vaccine industry.

The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (M Doses), revenue generated, and market share of different by Type (e.g., Injection, Freeze-Dried Powder).

Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Varicella Vaccine market.

Regional Analysis: The report involves examining the Varicella Vaccine market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.

Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Varicella Vaccine market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.

The report also involves a more granular approach to Varicella Vaccine:
Company Analysis: Report covers individual Varicella Vaccine manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.

Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Varicella Vaccine This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Kids Injection, Adults Injection).

Technology Analysis: Report covers specific technologies relevant to Varicella Vaccine. It assesses the current state, advancements, and potential future developments in Varicella Vaccine areas.

Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Varicella Vaccine market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.

Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.

Market Segmentation
Varicella Vaccine market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.

Market segment by Type
    Injection
    Freeze-Dried Powder

Market segment by Application
    Kids Injection
    Adults Injection

Major players covered
    Merck
    GSK
    Shanghai Institute
    BCHT
    Changsheng
    Keygen
    Green Cross
    Biken

Market segment by region, regional analysis covers
    North America (United States, Canada and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Varicella Vaccine product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Varicella Vaccine, with price, sales, revenue and global market share of Varicella Vaccine from 2019 to 2024.
Chapter 3, the Varicella Vaccine competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Varicella Vaccine breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2023.and Varicella Vaccine market forecast, by regions, type and application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Varicella Vaccine.
Chapter 14 and 15, to describe Varicella Vaccine sales channel, distributors, customers, research findings and conclusion.

Table of Contents

1 Market Overview
    1.1 Product Overview and Scope of Varicella Vaccine
    1.2 Market Estimation Caveats and Base Year
    1.3 Market Analysis by Type
        1.3.1 Overview: Global Varicella Vaccine Consumption Value by Type: 2019 Versus 2023 Versus 2030
        1.3.2 Injection
        1.3.3 Freeze-Dried Powder
    1.4 Market Analysis by Application
        1.4.1 Overview: Global Varicella Vaccine Consumption Value by Application: 2019 Versus 2023 Versus 2030
        1.4.2 Kids Injection
        1.4.3 Adults Injection
    1.5 Global Varicella Vaccine Market Size & Forecast
        1.5.1 Global Varicella Vaccine Consumption Value (2019 & 2023 & 2030)
        1.5.2 Global Varicella Vaccine Sales Quantity (2019-2030)
        1.5.3 Global Varicella Vaccine Average Price (2019-2030)

2 Manufacturers Profiles
    2.1 Merck
        2.1.1 Merck Details
        2.1.2 Merck Major Business
        2.1.3 Merck Varicella Vaccine Product and Services
        2.1.4 Merck Varicella Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.1.5 Merck Recent Developments/Updates
    2.2 GSK
        2.2.1 GSK Details
        2.2.2 GSK Major Business
        2.2.3 GSK Varicella Vaccine Product and Services
        2.2.4 GSK Varicella Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.2.5 GSK Recent Developments/Updates
    2.3 Shanghai Institute
        2.3.1 Shanghai Institute Details
        2.3.2 Shanghai Institute Major Business
        2.3.3 Shanghai Institute Varicella Vaccine Product and Services
        2.3.4 Shanghai Institute Varicella Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.3.5 Shanghai Institute Recent Developments/Updates
    2.4 BCHT
        2.4.1 BCHT Details
        2.4.2 BCHT Major Business
        2.4.3 BCHT Varicella Vaccine Product and Services
        2.4.4 BCHT Varicella Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.4.5 BCHT Recent Developments/Updates
    2.5 Changsheng
        2.5.1 Changsheng Details
        2.5.2 Changsheng Major Business
        2.5.3 Changsheng Varicella Vaccine Product and Services
        2.5.4 Changsheng Varicella Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.5.5 Changsheng Recent Developments/Updates
    2.6 Keygen
        2.6.1 Keygen Details
        2.6.2 Keygen Major Business
        2.6.3 Keygen Varicella Vaccine Product and Services
        2.6.4 Keygen Varicella Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.6.5 Keygen Recent Developments/Updates
    2.7 Green Cross
        2.7.1 Green Cross Details
        2.7.2 Green Cross Major Business
        2.7.3 Green Cross Varicella Vaccine Product and Services
        2.7.4 Green Cross Varicella Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.7.5 Green Cross Recent Developments/Updates
    2.8 Biken
        2.8.1 Biken Details
        2.8.2 Biken Major Business
        2.8.3 Biken Varicella Vaccine Product and Services
        2.8.4 Biken Varicella Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.8.5 Biken Recent Developments/Updates

3 Competitive Environment: Varicella Vaccine by Manufacturer
    3.1 Global Varicella Vaccine Sales Quantity by Manufacturer (2019-2024)
    3.2 Global Varicella Vaccine Revenue by Manufacturer (2019-2024)
    3.3 Global Varicella Vaccine Average Price by Manufacturer (2019-2024)
    3.4 Market Share Analysis (2023)
        3.4.1 Producer Shipments of Varicella Vaccine by Manufacturer Revenue ($MM) and Market Share (%): 2023
        3.4.2 Top 3 Varicella Vaccine Manufacturer Market Share in 2023
        3.4.2 Top 6 Varicella Vaccine Manufacturer Market Share in 2023
    3.5 Varicella Vaccine Market: Overall Company Footprint Analysis
        3.5.1 Varicella Vaccine Market: Region Footprint
        3.5.2 Varicella Vaccine Market: Company Product Type Footprint
        3.5.3 Varicella Vaccine Market: Company Product Application Footprint
    3.6 New Market Entrants and Barriers to Market Entry
    3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region
    4.1 Global Varicella Vaccine Market Size by Region
        4.1.1 Global Varicella Vaccine Sales Quantity by Region (2019-2030)
        4.1.2 Global Varicella Vaccine Consumption Value by Region (2019-2030)
        4.1.3 Global Varicella Vaccine Average Price by Region (2019-2030)
    4.2 North America Varicella Vaccine Consumption Value (2019-2030)
    4.3 Europe Varicella Vaccine Consumption Value (2019-2030)
    4.4 Asia-Pacific Varicella Vaccine Consumption Value (2019-2030)
    4.5 South America Varicella Vaccine Consumption Value (2019-2030)
    4.6 Middle East and Africa Varicella Vaccine Consumption Value (2019-2030)

5 Market Segment by Type
    5.1 Global Varicella Vaccine Sales Quantity by Type (2019-2030)
    5.2 Global Varicella Vaccine Consumption Value by Type (2019-2030)
    5.3 Global Varicella Vaccine Average Price by Type (2019-2030)

6 Market Segment by Application
    6.1 Global Varicella Vaccine Sales Quantity by Application (2019-2030)
    6.2 Global Varicella Vaccine Consumption Value by Application (2019-2030)
    6.3 Global Varicella Vaccine Average Price by Application (2019-2030)

7 North America
    7.1 North America Varicella Vaccine Sales Quantity by Type (2019-2030)
    7.2 North America Varicella Vaccine Sales Quantity by Application (2019-2030)
    7.3 North America Varicella Vaccine Market Size by Country
        7.3.1 North America Varicella Vaccine Sales Quantity by Country (2019-2030)
        7.3.2 North America Varicella Vaccine Consumption Value by Country (2019-2030)
        7.3.3 United States Market Size and Forecast (2019-2030)
        7.3.4 Canada Market Size and Forecast (2019-2030)
        7.3.5 Mexico Market Size and Forecast (2019-2030)

8 Europe
    8.1 Europe Varicella Vaccine Sales Quantity by Type (2019-2030)
    8.2 Europe Varicella Vaccine Sales Quantity by Application (2019-2030)
    8.3 Europe Varicella Vaccine Market Size by Country
        8.3.1 Europe Varicella Vaccine Sales Quantity by Country (2019-2030)
        8.3.2 Europe Varicella Vaccine Consumption Value by Country (2019-2030)
        8.3.3 Germany Market Size and Forecast (2019-2030)
        8.3.4 France Market Size and Forecast (2019-2030)
        8.3.5 United Kingdom Market Size and Forecast (2019-2030)
        8.3.6 Russia Market Size and Forecast (2019-2030)
        8.3.7 Italy Market Size and Forecast (2019-2030)

9 Asia-Pacific
    9.1 Asia-Pacific Varicella Vaccine Sales Quantity by Type (2019-2030)
    9.2 Asia-Pacific Varicella Vaccine Sales Quantity by Application (2019-2030)
    9.3 Asia-Pacific Varicella Vaccine Market Size by Region
        9.3.1 Asia-Pacific Varicella Vaccine Sales Quantity by Region (2019-2030)
        9.3.2 Asia-Pacific Varicella Vaccine Consumption Value by Region (2019-2030)
        9.3.3 China Market Size and Forecast (2019-2030)
        9.3.4 Japan Market Size and Forecast (2019-2030)
        9.3.5 Korea Market Size and Forecast (2019-2030)
        9.3.6 India Market Size and Forecast (2019-2030)
        9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
        9.3.8 Australia Market Size and Forecast (2019-2030)

10 South America
    10.1 South America Varicella Vaccine Sales Quantity by Type (2019-2030)
    10.2 South America Varicella Vaccine Sales Quantity by Application (2019-2030)
    10.3 South America Varicella Vaccine Market Size by Country
        10.3.1 South America Varicella Vaccine Sales Quantity by Country (2019-2030)
        10.3.2 South America Varicella Vaccine Consumption Value by Country (2019-2030)
        10.3.3 Brazil Market Size and Forecast (2019-2030)
        10.3.4 Argentina Market Size and Forecast (2019-2030)

11 Middle East & Africa
    11.1 Middle East & Africa Varicella Vaccine Sales Quantity by Type (2019-2030)
    11.2 Middle East & Africa Varicella Vaccine Sales Quantity by Application (2019-2030)
    11.3 Middle East & Africa Varicella Vaccine Market Size by Country
        11.3.1 Middle East & Africa Varicella Vaccine Sales Quantity by Country (2019-2030)
        11.3.2 Middle East & Africa Varicella Vaccine Consumption Value by Country (2019-2030)
        11.3.3 Turkey Market Size and Forecast (2019-2030)
        11.3.4 Egypt Market Size and Forecast (2019-2030)
        11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
        11.3.6 South Africa Market Size and Forecast (2019-2030)

12 Market Dynamics
    12.1 Varicella Vaccine Market Drivers
    12.2 Varicella Vaccine Market Restraints
    12.3 Varicella Vaccine Trends Analysis
    12.4 Porters Five Forces Analysis
        12.4.1 Threat of New Entrants
        12.4.2 Bargaining Power of Suppliers
        12.4.3 Bargaining Power of Buyers
        12.4.4 Threat of Substitutes
        12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain
    13.1 Raw Material of Varicella Vaccine and Key Manufacturers
    13.2 Manufacturing Costs Percentage of Varicella Vaccine
    13.3 Varicella Vaccine Production Process
    13.4 Varicella Vaccine Industrial Chain

14 Shipments by Distribution Channel
    14.1 Sales Channel
        14.1.1 Direct to End-User
        14.1.2 Distributors
    14.2 Varicella Vaccine Typical Distributors
    14.3 Varicella Vaccine Typical Customers

15 Research Findings and Conclusion

16 Appendix
    16.1 Methodology
    16.2 Research Process and Data Source
    16.3 Disclaimer

Table of Figures

List of Tables
    Table 1. Global Varicella Vaccine Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
    Table 2. Global Varicella Vaccine Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
    Table 3. Merck Basic Information, Manufacturing Base and Competitors
    Table 4. Merck Major Business
    Table 5. Merck Varicella Vaccine Product and Services
    Table 6. Merck Varicella Vaccine Sales Quantity (M Doses), Average Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 7. Merck Recent Developments/Updates
    Table 8. GSK Basic Information, Manufacturing Base and Competitors
    Table 9. GSK Major Business
    Table 10. GSK Varicella Vaccine Product and Services
    Table 11. GSK Varicella Vaccine Sales Quantity (M Doses), Average Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 12. GSK Recent Developments/Updates
    Table 13. Shanghai Institute Basic Information, Manufacturing Base and Competitors
    Table 14. Shanghai Institute Major Business
    Table 15. Shanghai Institute Varicella Vaccine Product and Services
    Table 16. Shanghai Institute Varicella Vaccine Sales Quantity (M Doses), Average Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 17. Shanghai Institute Recent Developments/Updates
    Table 18. BCHT Basic Information, Manufacturing Base and Competitors
    Table 19. BCHT Major Business
    Table 20. BCHT Varicella Vaccine Product and Services
    Table 21. BCHT Varicella Vaccine Sales Quantity (M Doses), Average Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 22. BCHT Recent Developments/Updates
    Table 23. Changsheng Basic Information, Manufacturing Base and Competitors
    Table 24. Changsheng Major Business
    Table 25. Changsheng Varicella Vaccine Product and Services
    Table 26. Changsheng Varicella Vaccine Sales Quantity (M Doses), Average Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 27. Changsheng Recent Developments/Updates
    Table 28. Keygen Basic Information, Manufacturing Base and Competitors
    Table 29. Keygen Major Business
    Table 30. Keygen Varicella Vaccine Product and Services
    Table 31. Keygen Varicella Vaccine Sales Quantity (M Doses), Average Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 32. Keygen Recent Developments/Updates
    Table 33. Green Cross Basic Information, Manufacturing Base and Competitors
    Table 34. Green Cross Major Business
    Table 35. Green Cross Varicella Vaccine Product and Services
    Table 36. Green Cross Varicella Vaccine Sales Quantity (M Doses), Average Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 37. Green Cross Recent Developments/Updates
    Table 38. Biken Basic Information, Manufacturing Base and Competitors
    Table 39. Biken Major Business
    Table 40. Biken Varicella Vaccine Product and Services
    Table 41. Biken Varicella Vaccine Sales Quantity (M Doses), Average Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 42. Biken Recent Developments/Updates
    Table 43. Global Varicella Vaccine Sales Quantity by Manufacturer (2019-2024) & (M Doses)
    Table 44. Global Varicella Vaccine Revenue by Manufacturer (2019-2024) & (USD Million)
    Table 45. Global Varicella Vaccine Average Price by Manufacturer (2019-2024) & (USD/Dose)
    Table 46. Market Position of Manufacturers in Varicella Vaccine, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2023
    Table 47. Head Office and Varicella Vaccine Production Site of Key Manufacturer
    Table 48. Varicella Vaccine Market: Company Product Type Footprint
    Table 49. Varicella Vaccine Market: Company Product Application Footprint
    Table 50. Varicella Vaccine New Market Entrants and Barriers to Market Entry
    Table 51. Varicella Vaccine Mergers, Acquisition, Agreements, and Collaborations
    Table 52. Global Varicella Vaccine Sales Quantity by Region (2019-2024) & (M Doses)
    Table 53. Global Varicella Vaccine Sales Quantity by Region (2025-2030) & (M Doses)
    Table 54. Global Varicella Vaccine Consumption Value by Region (2019-2024) & (USD Million)
    Table 55. Global Varicella Vaccine Consumption Value by Region (2025-2030) & (USD Million)
    Table 56. Global Varicella Vaccine Average Price by Region (2019-2024) & (USD/Dose)
    Table 57. Global Varicella Vaccine Average Price by Region (2025-2030) & (USD/Dose)
    Table 58. Global Varicella Vaccine Sales Quantity by Type (2019-2024) & (M Doses)
    Table 59. Global Varicella Vaccine Sales Quantity by Type (2025-2030) & (M Doses)
    Table 60. Global Varicella Vaccine Consumption Value by Type (2019-2024) & (USD Million)
    Table 61. Global Varicella Vaccine Consumption Value by Type (2025-2030) & (USD Million)
    Table 62. Global Varicella Vaccine Average Price by Type (2019-2024) & (USD/Dose)
    Table 63. Global Varicella Vaccine Average Price by Type (2025-2030) & (USD/Dose)
    Table 64. Global Varicella Vaccine Sales Quantity by Application (2019-2024) & (M Doses)
    Table 65. Global Varicella Vaccine Sales Quantity by Application (2025-2030) & (M Doses)
    Table 66. Global Varicella Vaccine Consumption Value by Application (2019-2024) & (USD Million)
    Table 67. Global Varicella Vaccine Consumption Value by Application (2025-2030) & (USD Million)
    Table 68. Global Varicella Vaccine Average Price by Application (2019-2024) & (USD/Dose)
    Table 69. Global Varicella Vaccine Average Price by Application (2025-2030) & (USD/Dose)
    Table 70. North America Varicella Vaccine Sales Quantity by Type (2019-2024) & (M Doses)
    Table 71. North America Varicella Vaccine Sales Quantity by Type (2025-2030) & (M Doses)
    Table 72. North America Varicella Vaccine Sales Quantity by Application (2019-2024) & (M Doses)
    Table 73. North America Varicella Vaccine Sales Quantity by Application (2025-2030) & (M Doses)
    Table 74. North America Varicella Vaccine Sales Quantity by Country (2019-2024) & (M Doses)
    Table 75. North America Varicella Vaccine Sales Quantity by Country (2025-2030) & (M Doses)
    Table 76. North America Varicella Vaccine Consumption Value by Country (2019-2024) & (USD Million)
    Table 77. North America Varicella Vaccine Consumption Value by Country (2025-2030) & (USD Million)
    Table 78. Europe Varicella Vaccine Sales Quantity by Type (2019-2024) & (M Doses)
    Table 79. Europe Varicella Vaccine Sales Quantity by Type (2025-2030) & (M Doses)
    Table 80. Europe Varicella Vaccine Sales Quantity by Application (2019-2024) & (M Doses)
    Table 81. Europe Varicella Vaccine Sales Quantity by Application (2025-2030) & (M Doses)
    Table 82. Europe Varicella Vaccine Sales Quantity by Country (2019-2024) & (M Doses)
    Table 83. Europe Varicella Vaccine Sales Quantity by Country (2025-2030) & (M Doses)
    Table 84. Europe Varicella Vaccine Consumption Value by Country (2019-2024) & (USD Million)
    Table 85. Europe Varicella Vaccine Consumption Value by Country (2025-2030) & (USD Million)
    Table 86. Asia-Pacific Varicella Vaccine Sales Quantity by Type (2019-2024) & (M Doses)
    Table 87. Asia-Pacific Varicella Vaccine Sales Quantity by Type (2025-2030) & (M Doses)
    Table 88. Asia-Pacific Varicella Vaccine Sales Quantity by Application (2019-2024) & (M Doses)
    Table 89. Asia-Pacific Varicella Vaccine Sales Quantity by Application (2025-2030) & (M Doses)
    Table 90. Asia-Pacific Varicella Vaccine Sales Quantity by Region (2019-2024) & (M Doses)
    Table 91. Asia-Pacific Varicella Vaccine Sales Quantity by Region (2025-2030) & (M Doses)
    Table 92. Asia-Pacific Varicella Vaccine Consumption Value by Region (2019-2024) & (USD Million)
    Table 93. Asia-Pacific Varicella Vaccine Consumption Value by Region (2025-2030) & (USD Million)
    Table 94. South America Varicella Vaccine Sales Quantity by Type (2019-2024) & (M Doses)
    Table 95. South America Varicella Vaccine Sales Quantity by Type (2025-2030) & (M Doses)
    Table 96. South America Varicella Vaccine Sales Quantity by Application (2019-2024) & (M Doses)
    Table 97. South America Varicella Vaccine Sales Quantity by Application (2025-2030) & (M Doses)
    Table 98. South America Varicella Vaccine Sales Quantity by Country (2019-2024) & (M Doses)
    Table 99. South America Varicella Vaccine Sales Quantity by Country (2025-2030) & (M Doses)
    Table 100. South America Varicella Vaccine Consumption Value by Country (2019-2024) & (USD Million)
    Table 101. South America Varicella Vaccine Consumption Value by Country (2025-2030) & (USD Million)
    Table 102. Middle East & Africa Varicella Vaccine Sales Quantity by Type (2019-2024) & (M Doses)
    Table 103. Middle East & Africa Varicella Vaccine Sales Quantity by Type (2025-2030) & (M Doses)
    Table 104. Middle East & Africa Varicella Vaccine Sales Quantity by Application (2019-2024) & (M Doses)
    Table 105. Middle East & Africa Varicella Vaccine Sales Quantity by Application (2025-2030) & (M Doses)
    Table 106. Middle East & Africa Varicella Vaccine Sales Quantity by Region (2019-2024) & (M Doses)
    Table 107. Middle East & Africa Varicella Vaccine Sales Quantity by Region (2025-2030) & (M Doses)
    Table 108. Middle East & Africa Varicella Vaccine Consumption Value by Region (2019-2024) & (USD Million)
    Table 109. Middle East & Africa Varicella Vaccine Consumption Value by Region (2025-2030) & (USD Million)
    Table 110. Varicella Vaccine Raw Material
    Table 111. Key Manufacturers of Varicella Vaccine Raw Materials
    Table 112. Varicella Vaccine Typical Distributors
    Table 113. Varicella Vaccine Typical Customers
List of Figures
    Figure 1. Varicella Vaccine Picture
    Figure 2. Global Varicella Vaccine Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
    Figure 3. Global Varicella Vaccine Consumption Value Market Share by Type in 2023
    Figure 4. Injection Examples
    Figure 5. Freeze-Dried Powder Examples
    Figure 6. Global Varicella Vaccine Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
    Figure 7. Global Varicella Vaccine Consumption Value Market Share by Application in 2023
    Figure 8. Kids Injection Examples
    Figure 9. Adults Injection Examples
    Figure 10. Global Varicella Vaccine Consumption Value, (USD Million): 2019 & 2023 & 2030
    Figure 11. Global Varicella Vaccine Consumption Value and Forecast (2019-2030) & (USD Million)
    Figure 12. Global Varicella Vaccine Sales Quantity (2019-2030) & (M Doses)
    Figure 13. Global Varicella Vaccine Average Price (2019-2030) & (USD/Dose)
    Figure 14. Global Varicella Vaccine Sales Quantity Market Share by Manufacturer in 2023
    Figure 15. Global Varicella Vaccine Consumption Value Market Share by Manufacturer in 2023
    Figure 16. Producer Shipments of Varicella Vaccine by Manufacturer Sales Quantity ($MM) and Market Share (%): 2023
    Figure 17. Top 3 Varicella Vaccine Manufacturer (Consumption Value) Market Share in 2023
    Figure 18. Top 6 Varicella Vaccine Manufacturer (Consumption Value) Market Share in 2023
    Figure 19. Global Varicella Vaccine Sales Quantity Market Share by Region (2019-2030)
    Figure 20. Global Varicella Vaccine Consumption Value Market Share by Region (2019-2030)
    Figure 21. North America Varicella Vaccine Consumption Value (2019-2030) & (USD Million)
    Figure 22. Europe Varicella Vaccine Consumption Value (2019-2030) & (USD Million)
    Figure 23. Asia-Pacific Varicella Vaccine Consumption Value (2019-2030) & (USD Million)
    Figure 24. South America Varicella Vaccine Consumption Value (2019-2030) & (USD Million)
    Figure 25. Middle East & Africa Varicella Vaccine Consumption Value (2019-2030) & (USD Million)
    Figure 26. Global Varicella Vaccine Sales Quantity Market Share by Type (2019-2030)
    Figure 27. Global Varicella Vaccine Consumption Value Market Share by Type (2019-2030)
    Figure 28. Global Varicella Vaccine Average Price by Type (2019-2030) & (USD/Dose)
    Figure 29. Global Varicella Vaccine Sales Quantity Market Share by Application (2019-2030)
    Figure 30. Global Varicella Vaccine Consumption Value Market Share by Application (2019-2030)
    Figure 31. Global Varicella Vaccine Average Price by Application (2019-2030) & (USD/Dose)
    Figure 32. North America Varicella Vaccine Sales Quantity Market Share by Type (2019-2030)
    Figure 33. North America Varicella Vaccine Sales Quantity Market Share by Application (2019-2030)
    Figure 34. North America Varicella Vaccine Sales Quantity Market Share by Country (2019-2030)
    Figure 35. North America Varicella Vaccine Consumption Value Market Share by Country (2019-2030)
    Figure 36. United States Varicella Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 37. Canada Varicella Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 38. Mexico Varicella Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 39. Europe Varicella Vaccine Sales Quantity Market Share by Type (2019-2030)
    Figure 40. Europe Varicella Vaccine Sales Quantity Market Share by Application (2019-2030)
    Figure 41. Europe Varicella Vaccine Sales Quantity Market Share by Country (2019-2030)
    Figure 42. Europe Varicella Vaccine Consumption Value Market Share by Country (2019-2030)
    Figure 43. Germany Varicella Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 44. France Varicella Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 45. United Kingdom Varicella Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 46. Russia Varicella Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 47. Italy Varicella Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 48. Asia-Pacific Varicella Vaccine Sales Quantity Market Share by Type (2019-2030)
    Figure 49. Asia-Pacific Varicella Vaccine Sales Quantity Market Share by Application (2019-2030)
    Figure 50. Asia-Pacific Varicella Vaccine Sales Quantity Market Share by Region (2019-2030)
    Figure 51. Asia-Pacific Varicella Vaccine Consumption Value Market Share by Region (2019-2030)
    Figure 52. China Varicella Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 53. Japan Varicella Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 54. Korea Varicella Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 55. India Varicella Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 56. Southeast Asia Varicella Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 57. Australia Varicella Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 58. South America Varicella Vaccine Sales Quantity Market Share by Type (2019-2030)
    Figure 59. South America Varicella Vaccine Sales Quantity Market Share by Application (2019-2030)
    Figure 60. South America Varicella Vaccine Sales Quantity Market Share by Country (2019-2030)
    Figure 61. South America Varicella Vaccine Consumption Value Market Share by Country (2019-2030)
    Figure 62. Brazil Varicella Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 63. Argentina Varicella Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 64. Middle East & Africa Varicella Vaccine Sales Quantity Market Share by Type (2019-2030)
    Figure 65. Middle East & Africa Varicella Vaccine Sales Quantity Market Share by Application (2019-2030)
    Figure 66. Middle East & Africa Varicella Vaccine Sales Quantity Market Share by Region (2019-2030)
    Figure 67. Middle East & Africa Varicella Vaccine Consumption Value Market Share by Region (2019-2030)
    Figure 68. Turkey Varicella Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 69. Egypt Varicella Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 70. Saudi Arabia Varicella Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 71. South Africa Varicella Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 72. Varicella Vaccine Market Drivers
    Figure 73. Varicella Vaccine Market Restraints
    Figure 74. Varicella Vaccine Market Trends
    Figure 75. Porters Five Forces Analysis
    Figure 76. Manufacturing Cost Structure Analysis of Varicella Vaccine in 2023
    Figure 77. Manufacturing Process Analysis of Varicella Vaccine
    Figure 78. Varicella Vaccine Industrial Chain
    Figure 79. Sales Quantity Channel: Direct to End-User vs Distributors
    Figure 80. Direct Channel Pros & Cons
    Figure 81. Indirect Channel Pros & Cons
    Figure 82. Methodology
    Figure 83. Research Process and Data Source

Companies Mentioned

Merck
GSK
Shanghai Institute
BCHT
Changsheng
Keygen
Green Cross
Biken